ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,203Medicare Part D Prescriptions Filled, Including Refills

Rank: 323 out of 780

$413K Total Retail Price of All Prescriptions

Rank: 365 out of 780

532 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 532 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 5,357 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
AMLODIPINE BESYLATE 527 302 1 4
HYDROCHLOROTHIAZIDE 436 271 2 10
FOSINOPRIL SODIUM 357 266 3 112
HYDROCODONE-ACETAMINOPHEN 343 230 S3 4 1
METFORMIN HCL 305 148 5 8
PRAVASTATIN SODIUM 281 189 6 9
SIMVASTATIN 260 169 7 2
CARVEDILOL 224 146 8 14
LOSARTAN POTASSIUM 210 139 9 18
FUROSEMIDE 207 136 10 7
RANITIDINE HCL 198 106 11 39
TRAMADOL HCL 192 116 12 15
CLONIDINE HCL 177 117 13 28
LISINOPRIL 167 80 14 6
DOXAZOSIN MESYLATE 167 121 14 97
HYDRALAZINE HCL 141 110 16 54
FELODIPINE ER 132 96 17 126
GABAPENTIN 131 49 18 13
METOPROLOL SUCCINATE 127 75 19 20
OMEPRAZOLE 118 51 20 3
INSULIN SYRINGE 113 51 21 80
CYCLOBENZAPRINE HCL 113 18 R 21 42
KLOR-CON 10 112 64 23 90
NEXIUM 105 50 24 22
ATENOLOL 105 46 24 21
ALENDRONATE SODIUM 99 81 26 44
METOPROLOL TARTRATE 97 64 27 19
DIOVAN 97 58 27 55
POTASSIUM CHLORIDE 95 72 29 11
FLUTICASONE PROPIONATE 92 41 30 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 40 31 26
NOVOLIN 70-30 80 38 32 164
MELOXICAM 79 61 33 16
CHLORTHALIDONE 78 39 34 142
FLUOXETINE HCL 77 39 35 65
BENAZEPRIL HCL 74 39 36 59
HYDROXYZINE HCL 74 21 R 36 155
WARFARIN SODIUM 71 29 38 24
TRAZODONE HCL 68 45 39 35
NAPROXEN 67 34 40 100
HUMULIN 70-30 65 25 41 106
PROAIR HFA 64 30 42 62
PAROXETINE HCL 63 0 43 69
ADVAIR DISKUS 63 39 43 68
GLYBURIDE 61 46 R 45 101
ATORVASTATIN CALCIUM 61 38 45 12
AMITRIPTYLINE HCL 61 14 R 45 48
NIFEDIPINE ER 60 48 48 115
CRESTOR 57 34 49 32
LEVOTHYROXINE SODIUM 56 42 50 5
GLIPIZIDE ER 54 48 51 109
ALLOPURINOL 50 26 52 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.